These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 9531186)
1. Treatment of membranous lupus nephritis. Moroni G; Maccario M; Banfi G; Quaglini S; Ponticelli C Am J Kidney Dis; 1998 Apr; 31(4):681-6. PubMed ID: 9531186 [TBL] [Abstract][Full Text] [Related]
2. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. Ponticelli C; Zucchelli P; Passerini P; Cagnoli L; Cesana B; Pozzi C; Pasquali S; Imbasciati E; Grassi C; Redaelli B N Engl J Med; 1989 Jan; 320(1):8-13. PubMed ID: 2642605 [TBL] [Abstract][Full Text] [Related]
3. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Passerini P; Grassi C; Limido D; Pasquali S; Volpini T N Engl J Med; 1984 Apr; 310(15):946-50. PubMed ID: 6366560 [TBL] [Abstract][Full Text] [Related]
4. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. Ponticelli C; Zucchelli P; Passerini P; Cesana B N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ]. Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309 [TBL] [Abstract][Full Text] [Related]
6. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome. Polenakovic M; Grcevska L; Dzikova S Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive treatment of the glomerulonephritis of systemic lupus. Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548 [TBL] [Abstract][Full Text] [Related]
8. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252 [TBL] [Abstract][Full Text] [Related]
9. Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up. Moroni G; Gallelli B; Quaglini S; Banfi G; Rivolta E; Messa P; Ponticelli C Nephrol Dial Transplant; 2006 Jun; 21(6):1541-8. PubMed ID: 16455674 [TBL] [Abstract][Full Text] [Related]
11. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study. Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651 [TBL] [Abstract][Full Text] [Related]
12. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy. Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643 [TBL] [Abstract][Full Text] [Related]
14. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Ponticelli C; Villa M; Banfi G; Cesana B; Pozzi C; Pani A; Passerini P; Farina M; Grassi C; Baroli A Am J Kidney Dis; 1999 Oct; 34(4):618-25. PubMed ID: 10516340 [TBL] [Abstract][Full Text] [Related]
15. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782 [TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A in treatment of membranous lupus nephropathy. Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467 [TBL] [Abstract][Full Text] [Related]
17. Chlorambucil treatment of frequently relapsing nephrotic syndrome. Grupe WE; Makker SP; Ingelfinger JR N Engl J Med; 1976 Sep; 295(14):746-9. PubMed ID: 958261 [TBL] [Abstract][Full Text] [Related]
18. Membranous nephropathy. Long-term follow-up and association with neoplasia. Row PG; Cameron JS; Turner DR; Evans DJ; White RH; Ogg CS; Chantler C; Brown CB Q J Med; 1975 Apr; 44(174):207-39. PubMed ID: 1178811 [TBL] [Abstract][Full Text] [Related]
19. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis. Opastirakul S; Chartapisak W J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070 [TBL] [Abstract][Full Text] [Related]
20. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome. Griveas I; Visvardis G; Papadopoulou D; Nakopolou L; Karanikas E; Gogos K; Stavianoudakis G Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]